|Bid||0.00 x 800|
|Ask||14.57 x 308300|
|Day's Range||14.74 - 14.98|
|52 Week Range||13.11 - 15.21|
|PE Ratio (TTM)||N/A|
|Beta (3Y Monthly)||-0.06|
|Expense Ratio (net)||0.50%|
U.S. stock indices were again quiet on Wednesday, as we begin to chip away at the tip of the earnings iceberg. We're mostly delving through the banks right now, but will have tech and other industries beginning soon. Let's look at a few top stock trades. Top Stock Trades for Tomorrow 1: Tesla Click to EnlargeTesla (NASDAQ:TSLA) stock has been moving favorably, working on its seventh straight week of gains. InvestorPlace - Stock Market News, Stock Advice & Trading TipsIt's getting into a very key area though, the $250 to $260 zone. This was prior range support for years, buoying Tesla stock on each test. Back in May, the stock plunged below this mark, rebounded the next week and failed to reclaim it. * 4 Retail Stocks to Buy in Time for the Back-to-School Rush This is all shown via the purple arrow on the chart and shows when an area shifts from support to resistance. Now back in this area, it's vital for TSLA stock to reclaim this range level in order to keep the rally alive. Those who bought Tesla sub-$200 as a trade may consider booking some profits here. Should shares push through, look for a rally up to the 200-week moving average, currently at $273. On a pullback, see that the 10-week holds as support. I wouldn't want to see Tesla below $240. Top Stock Trades for Tomorrow 2: Abbott Labs Click to EnlargeAbbott Labs (NYSE:ABT) hit new highs after the company reported earnings. However, the stock is not moving as robustly as one might have expected. I want to see ABT stock hold $85 on the downside and see if it can push up to channel resistance on the upside. Top Stock Trades for Tomorrow 3: Gold Click to EnlargeThe move has been years in the making, but the SPDR Gold ETF (NYSEARCA:GLD) is starting to make some waves. The iShares Silver Trust ETF (NYSEARCA:SLV) has been trading well too, but isn't putting together the kind of chart GLD is. Above is a long-term weekly chart. With GLD over the $128 to $130 area, it's in breakout mode. While shares are putting in a nice bull flag setup after a huge burst higher in June, we absolutely need to see prior resistance hold as support. A rate cut should help fuel a rally for gold, although the market is surely starting to price in such an event. Over $135.55 sends GLD even higher. A pullback to $130 or the 10-day moving average that holds as support may be a buy-the-dip opportunity. Top Stock Trades for Tomorrow 4: Invitae Click to EnlargeShares of Invitae (NASDAQ:NVTA) took off Wednesday, rallying up toward $24 at one point in the day. Citron Research said it had a position in the name and is using a $100 price target. We've been telling InvestorPlace readers for months that we love this name. Today's action came with perfect timing. On Twitter on Tuesday, we pointed out that NVTA stock broke below the 20-day moving average, but reclaimed this mark by the close. That was very constructive action, while Wednesday's action has been downright impressive. The action is similar to what we saw last month, where shares broke below the 20-day, reclaimed it in the same session, then went on a monster run over the next few days. I'm not sure that history repeats, but investors are hopeful that it will. Let's see if NVTA can push through $24 to $24.50. If it can, $26+ could be in the cards. Top Stock Trades for Tomorrow 5: Teva Pharmaceutical Click to EnlargeShares of Teva Pharmaceutical (NYSE:TEVA) are taking it on the chin. The stock is down 11% in just three days and more than 20% from its highs earlier this month. * 8 Penny Stocks That Have Fallen From Grace The stock hit new 52-week lows on the move and is threatening to fall below $8 support. Longs with a strong stomach can play against Wednesday's lows, but Teva has not been a great one to own. A break below $8 could accelerate the selling pressure. A rally could bring Teva back up to its 20-day moving average. Above that and $10 is possible. Bret Kenwell is the manager and author of Future Blue Chips and is on Twitter @BretKenwell. As of this writing, Bret Kenwell is long NVTA. More From InvestorPlace * 2 Toxic Pot Stocks You Should Avoid * 9 Retail Stocks Goldman Sachs Says Are Ready to Rip * 7 Services Stocks to Buy for the Rest of 2019 * 6 Stocks to Buy and 1 to Sell Based on Insider Trading The post 5 Top Stock Trades for Thursday: TSLA, GLD, ABT appeared first on InvestorPlace.
Gold Recovers after “Trade Deal Progress” Fall It didn’t take gold (NYSEARCA:GLD) long to recover after declining to $1,384 on Monday on news of the best meeting ever between President Trump and Chinese President Xi Jinping on Monday. Xi promised to buy US agriculture, even though the Chinese government doesn’t actually buy food, but rather […]The post Market Morning: Gold Slingshot, Cannabis Consolidation, Baidu Debacle, Vietnam Tariff Bazooka appeared first on Market Exclusive.
In this daily bar chart of SLV, below, we can see that prices made a bottom back in September-November, followed by a rally into February and a retest in May. This month saw SLV rally above the rising 50-day moving average line as well as the now bullish 200-day line. Notice the rising On-Balance-Volume (OBV) line from November to June? Prices are now above the bottoming 40-week moving average line.
Investing in silver commodities ETFs essentially means you can profit from the price movement of silver without physically owning the metal.
Gold futures rally Friday, posting their highest finish in over seven weeks, as investors flee to the perceived safety of havens like precious metals amid fresh signs of escalation in tariff tensions between the U.S. and its global trade partners.
Lackluster trading in gold futures Thursday gives way to a solid move higher, as tepid trade in equity markets and persistent worries about U.S.-China trade tensions and sluggish global economic growth help lift prices to their highest finish in roughly two weeks.
- Investigational New Drug (IND) application to conduct a Phase 1 study of selective CDK8 inhibitor SEL120 cleared by U.S. Food and Drug Administration (FDA) - Dosing of first patient in Phase 1 study ...
KRAKOW , Poland , May 13, 2019 /PRNewswire/ -- Selvita (WSE: SLV), a clinical stage drug discovery and development company engaged in the research and development of novel cancer therapies, today announced ...
Sometimes the U.S. stock market sends a clear, unambiguous message. The message the stock market sent during Federal Reserve Chairman Jerome Powell’s press conference Wednesday says that the market is vulnerable. • The chart shows that the stock market rose immediately after the Fed decision was announced.
Newmont Mining Beats Q1 Earnings Estimates(Continued from Prior Part)Newmont-Goldcorp mergerAs we highlighted in Newmont (NEM) and Goldcorp Merge, Form World’s Largest Gold Company, the merger of Newmont and Goldcorp was completed on April 18.
While many traders have given up on the idea of a bounce in silver prices, several chart patterns suggest a potential move higher.
Banks will highlight first-quarter earnings for 2019 on Friday, which could give precious metals a jolt of gains if the weak guidance expected by a number of corporations translates to a move to safe-haven assets. Of course, the strength of precious metals will be tied to the Fed and their interest rate policy in correlation with the dollar. Increased dovishness by the central bank could continue to feed into safe-haven asset like precious metals.
To help investors keep up with the markets, we present our ETF Scorecard. The Scorecard takes a step back and looks at how various asset classes across the globe are performing. The weekly performance is from last Friday’s open to this week’s Thursday close.
A strong U.S. dollar on Thursday caused precious metals to fall as seen in exchange-traded funds (ETFs) like the SPDR Gold Shares (GLD) and the iShares Silver Trust (SLV) . Gold prices reached a three-week low and silver touched down to a three-month low as the dollar rose to a multi-month high. Another precious metal, palladium, fell 16 percent from the previous week's highs.
KRAKOW, Poland, March 28, 2019 /PRNewswire/ -- Selvita (SLV.WA), a clinical stage company engaged in the research and development of novel cancer therapies as well as provision of drug discovery and development services, today announced that it plans to separate into two companies. One company will focus on development of small molecule therapeutics in oncology and the other will provide contract research services.
KRAKOW, Poland, March 28, 2019 /PRNewswire/ -- Selvita (SLV.WA), a clinical stage company engaged in the research and development of novel cancer therapies as well as provision of drug discovery and development services, today announced that it has, recognized dynamic growth last year in the Services Division. The segment's revenues from external clients amounted to PLN59.1M, which represents an increase of 34% y/y, higher than expected 30% growth. Operating profit in the Services Division rose by 67% to PLN8.8M.
Each day, Benzinga takes a look back at a notable market-related moment that occurred on this date. What Happened? The Dow finished the day at 759.98. Today, the Dow is trading at 25,202.60 and the S&P 500 is trading at 2,658.55. What Else Was Going On In The World?
KRAKOW, Poland, March 26, 2019 /PRNewswire/ -- Selvita (SLV.WA), a clinical stage company engaged in the research and development of novel cancer therapies as well as provision of drug discovery and development services, today announced that the U.S. Food and Drug Administration (FDA) has cleared its Investigational New Drug (IND) application to conduct a Phase 1 study of selective CDK8 inhibitor SEL120 in patients with acute myeloid leukemia (AML) or high-risk myelodysplastic syndrome (HR-MDS). The open-label, dose-escalation study is designed to evaluate safety and tolerability of SEL120 as well as to establish the recommended dose of SEL120 for subsequent clinical development.
Market Freaks Out Over Yield Curve Inversion A Bit Prematurely In what looked like a positive feedback loop on Friday, long term interest rates began to crash, sending the S&P 500 (NYSEARCA:SPY) down nearly 2% and holding at the 2,800 support level. The 10Y Treasury yield was down over 10 basis points, while short term […]The post Market Morning: Yield Curve Hysteria, Bitcoin Trading Faked, Brexit Goes Bananas, Mueller Report Out appeared first on Market Exclusive.
KRAKOW , Poland , March 21, 2019 /PRNewswire/ -- Selvita (WSE: SLV), a clinical stage company engaged in the research and development of novel cancer therapies as well as provision of drug discovery and ...
Which Gold Miners Are in Sound Financial Health after 2018?Leverage ratiosIn the gold mining space, it’s important for investors to look at the companies’ DE (debt-to-equity) ratio. A company’s DE ratio shows the DE mix in its capital